Brazil at the center of chikungunya outbreaks by J Kennedy Amaral, Peter C Taylor, Robert T Schoen

Get full text

Obituary: Peter William Robertson (7 July 1945–6 July 2022) by Peter C. Taylor, Mark J. Ferson, William D. Rawlinson

Get full text

Outcomes Following Adalimumab Bio-originator to Biosimilar Switch—A Comparison Using Real-world Patient- and Physician-Reported Data in European Countries by Peter C. Taylor, Yuri Sanchez Gonzalez, Ryan Clark, Freddy Faccin, Oliver Howell

Get full text

Managing inadequate response to initial anti-TNF therapy in rheumatoid arthritis: optimising treatment outcomes by Peter C. Taylor, Marco Matucci Cerinic, Rieke Alten, Jérôme Avouac, Rene Westhovens

Get full text

Development of Carbon Fiber-modified Electrically Conductive Concrete for Implementation in Des Moines International Airport by Alireza Sassani, Halil Ceylan, Sunghwan Kim, Ali Arabzadeh, Peter C. Taylor, Kasthurirangan Gopalakrishnan

Get full text

Biological Therapies in Immune-Mediated Inflammatory Diseases: Can Biosimilars Reduce Access Inequities? by Daniel C. Baumgart, Daniel C. Baumgart, Laurent Misery, Sue Naeyaert, Peter C. Taylor

Get full text

The Key Comorbidities in Patients with Rheumatoid Arthritis: A Narrative Review by Peter C. Taylor, Fabiola Atzeni, Alejandro Balsa, Laure Gossec, Ulf Müller-Ladner, Janet Pope

Get full text

Highway infrastructure health monitoring using micro-electromechanical sensors and systems (MEMS) by Halil Ceylan, Kasthurirangan Gopalakrishnan, Sunghwan Kim, Peter C. Taylor, Maxim Prokudin, Ashley F. Buss

Get full text

The Clinical Features, Pathogenesis and Methotrexate Therapy of Chronic Chikungunya Arthritis by J. Kennedy Amaral, Peter C. Taylor, Mauro Martins Teixeira, Thomas E. “Tem” Morrison, Robert T. Schoen

Get full text

Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active disease by Peter C. Taylor, Ayman Askari, Ernest Choy, Michael R. Ehrenstein, Sara Else, Muhammad K. Nisar

Get full text

Polyurethane-carbon microfiber composite coating for electrical heating of concrete pavement surfaces by Alireza Sassani, Ali Arabzadeh, Halil Ceylan, Sunghwan Kim, Kasthurirangan Gopalakrishnan, Peter C. Taylor, Ali Nahvi

Get full text

Itch as Major Mediator of Effect of Tofacitinib on Health-Related Quality of Life in Psoriatic Arthritis: A Mediation Analysis by Peter C. Taylor, Andrew G. Bushmakin, Joseph C. Cappelleri, Pamela Young, Rebecca Germino, Joseph F. Merola, Gil Yosipovitch

Get full text

The effect of tofacitinib on residual pain in patients with rheumatoid arthritis and psoriatic arthritis by Maxime Dougados, Peter C Taylor, Clifton O Bingham, Lisy Wang, Lara Fallon, Satrajit Roychoudhury, Yves Brault, Meriem Kessouri

Get full text

Relationships of dermatologic symptoms and quality of life in patients with psoriatic arthritis: analysis of two tofacitinib phase III studies by Peter C. Taylor, Andrew G. Bushmakin, Joseph C. Cappelleri, Pamela Young, Rebecca Germino, Joseph F. Merola, Gil Yosipovitch

Get full text

Safety of Repeated Open-Label Treatment Courses of Intravenous Ofatumumab, a Human Anti-CD20 Monoclonal Antibody, in Rheumatoid Arthritis: Results from Three Clinical Trials. by Emilia Quattrocchi, Mikkel Østergaard, Peter C Taylor, Ronald F van Vollenhoven, Myron Chu, Stephen Mallett, Hayley Perry, Regina Kurrasch

Get full text

Most Trial Eligibility Criteria and Patient Baseline Characteristics Do Not Modify Treatment Effect in Trials Using Targeted Therapies for Rheumatoid Arthritis: A Meta-Epidemiologi... by Anton Wulf Christensen, Simon Tarp, Daniel E Furst, Anna Døssing, Kirstine Amris, Henning Bliddal, Peter C Taylor, Robin Christensen

Get full text

Pain and Inflammation as Mediators of Tofacitinib Treatment Effect on Fatigue in Patients with Ankylosing Spondylitis: A Mediation Analysis by Lars Erik Kristensen, Victoria Navarro-Compán, Marina Magrey, Andrew G. Bushmakin, Joseph C. Cappelleri, Arne Yndestad, Oluwaseyi Dina, Peter C. Taylor

Get full text

Efficacy and safety of namilumab, a human monoclonal antibody against granulocyte-macrophage colony-stimulating factor (GM-CSF) ligand in patients with rheumatoid arthritis (RA) wi... by Peter C. Taylor, Didier Saurigny, Jiri Vencovsky, Tsutomu Takeuchi, Tadashi Nakamura, Galina Matsievskaia, Barbara Hunt, Thomas Wagner, Bernard Souberbielle, for the NEXUS Study Group

Get full text

Filgotinib Modulates Inflammation-Associated Peripheral Blood Protein Biomarkers in Adults with Active Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate by Yoshiya Tanaka, Peter C. Taylor, Emon Elboudwarej, Angie Hertz, Xiaorong Shao, Vladislav A. Malkov, Hironori Matsushima, Kahaku Emoto, Bryan Downie, Tsutomu Takeuchi

Get full text

Correction: Filgotinib Modulates Inflammation-Associated Peripheral Blood Protein Biomarkers in Adults with Active Rheumatoid Arthritis and Prior Inadequate Response to Methotrexat... by Yoshiya Tanaka, Peter C. Taylor, Emon Elboudwarej, Angie Hertz, Xiaorong Shao, Vladislav A. Malkov, Hironori Matsushima, Kahaku Emoto, Bryan Downie, Tsutomu Takeuchi

Get full text